C533 (Tenofovir Disoproxil Fumarate 300 mg)

Pill with imprint C533 is Blue, Capsule-shape and has been identified as Tenofovir Disoproxil Fumarate 300 mg. It is supplied by Cipla USA Inc..

Tenofovir is used in the treatment of hepatitis b; hiv infection; nonoccupational exposure; occupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). There is no proven risk in humans during pregnancy. Tenofovir 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for C533

Tenofovir Disoproxil Fumarate

Imprint

C533

Strength

300 mg

Color

Blue

Size

17.00 mm

Shape

Capsule-shape

Availability

Prescription only

Drug Class

Nucleoside reverse transcriptase inhibitors (NRTIs)

Pregnancy Category

B - No proven risk in humans

CSA Schedule

Not a controlled drug

Labeler / Supplier

Cipla USA Inc.

National Drug Code (NDC)

69097-0533

Inactive Ingredients

lactose monohydrate, croscarmellose sodium, corn starch, polysorbate 80, microcrystalline cellulose, magnesium stearate, titanium dioxide, triacetin, FD&C Blue No. 2, hypromellose 2910 (15 mPa.s)

Note: Inactive ingredients may vary.

More Info Imprint Search Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer